EPS

A 57% stock plunge and a securities fraud lawsuit against Embecta Corp. reveal the high stakes of corporate guidance and the new era of accountability.

Butterfield's latest earnings show a drop in net income, but a look past the headline numbers reveals a bank aggressively expanding its Caribbean footprint.

The specialized REIT surpasses Q2 expectations and raises its 2026 guidance, capitalizing on a surge in defense spending and robust demand for its secure properties.

CBNK posts strong Q2 growth in loans and deposits, validating its strategy. But a closer look reveals rising credit risks and shrinking margins.

Immersion's revenue soars post-BNED deal, but profits plummet. Can a haptics innovator thrive while managing an education giant and keep investors happy?

A 30% profit drop at Ohio Valley Banc Corp. highlights a risky strategy: funding rapid loan growth with costly deposits as major credit issues emerge.

With its stock down 80% after losing a key contract, Verra Mobility's upcoming Q2 earnings call is a crucial test for its new interim leadership.

SLB's Q2 revenue hits $8.97B, up 5% YoY, as its strategic pivot to digital and data centers successfully navigates geopolitical turmoil in the Middle East.

Michigan's ChoiceOne Bank takes a deliberate Q2 earnings hit to fund robust loan growth and expand its footprint, signaling a long-term strategy over short-term gains.

Oregon Pacific Bancorp's Q2 results show impressive profit growth and smart financial management, but a sharp rise in classified assets raises critical questions.

As Jamieson Wellness preps its Q2 results, investors are watching closely. Will its Canadian strength offset U.S. struggles and define its path forward?

Tenet Healthcare's blockbuster Q2 results beat all estimates, driven by its ambulatory surgery unit and a strategic focus on complex procedures, raising its annual forecast.

Hanover Bancorp posts record profits and expands its margin, but the real story lies in its new leadership, Long Island expansion, and a delicate balance of growth and risk.

SouthState Bank posts strong Q2 earnings with a dividend hike, driven by solid loan growth, stable margins, and a quiet but strategic investment in AI.

With a mixed Q1 and a promise of a stronger second half, Myriad Genetics' upcoming earnings call will be a crucial test of its strategic health and pipeline.

The Exton-based bank didn't just post record profits; it showed how disciplined growth, pristine asset quality, and smart funding can defy industry trends.

After a blockbuster Q1, BRC Group Holdings faces intense scrutiny. Can its multi-sector strategy weather economic headwinds and justify recent stock volatility?

Packaging giant PCA battles soaring freight costs with record shipment volumes, offering a crucial look at the physical infrastructure straining under digital demand.

Natural Resource Partners' Q2 results are a crucial test of its strategic pivot. Can new energy and industrial minerals offset legacy market volatility?

As Granite Point prepares its Q2 report, investors watch for signs of a strategic pivot from resolving legacy debt to new loan origination in a tight market.